COMMUNIQUÉS West-GlobeNewswire

Minerva Neurosciences to Report Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2018
05/03/2018
WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2018 After Market Close on March 12, 2018
05/03/2018
TUSTIN, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
iRestore Hair Growth System Launches Hair Gummy Vitamins for Healthier, Fuller Hair
05/03/2018
LOS ANGELES, March 05, 2018 (GLOBE NEWSWIRE) -- Creator of the FDA-cleared at-home iRestore Laser Hair Growth System , Freedom Laser Therapy , today launches iRestore Hair Gummy Vitamins for optimal hair health, [...]
Allscripts and Lyft partner to eliminate transportation barriers to healthcare
05/03/2018
LAS VEGAS, March 05, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) and Lyft, the fastest growing rideshare company in the U.S., are joining forces to incorporate non-emergency transportation directly into the [...]
Cellectar Biosciences to Present at Upcoming March Conferences
05/03/2018
MADISON, Wis., March 05, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]
CymaBay Therapeutics to Participate in Upcoming Investor Conferences in March
05/03/2018
NEWARK, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
Abiomed Showcases Impella® Technology that Enables Heart Recovery at ACC with 25 Presentations
05/03/2018
DANVERS, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support and recovery technologies, announces that there are more than 25 presentations scheduled [...]
Biotricity Announces Commercial Rollout of Proprietary Bioflux Device
05/03/2018
REDWOOD CITY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]
Sorrento Therapeutics Autologous Anti-CEA CAR-T Cell Therapy for Liver Metastases Demonstrates Therapeutic Activity in Stage IV Pancreas Cancer in a Phase 1b HITM-SURE Trial (NCT02850536)
05/03/2018
SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) (“Sorrento”), cellular therapy focused subsidiary, TNK Therapeutics, Inc. (“TNK”), and Surefire Medical, Inc., announced today [...]
Daré Bioscience, Inc. To Participate in the 30th Annual ROTH Conference
05/03/2018
SAN DIEGO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, today announced that Sabrina Martucci Johnson, President and Chief [...]
Epilepsy Foundation Awards $200,000 at ‘Shark Tank’ Competition for Innovative Products that Aim to Improve Epilepsy Treatment and Care
05/03/2018
LANDOVER, Md., March 05, 2018 (GLOBE NEWSWIRE) -- The Epilepsy Foundation announced the winners of the 2018 Shark Tank competition for innovative ideas in epilepsy and seizure treatment and care on February 22, 2018, at [...]
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
05/03/2018
CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it [...]
Genocea to Present at Two March Investor Conferences
05/03/2018
CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Chip Clark, president and chief [...]
Neos Therapeutics to Present at the Cowen & Co. Annual Health Care Conference
05/03/2018
DALLAS and FORT WORTH, Texas, March 05, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR [...]
Onconova Therapeutics Announces License Agreement with Pint Pharma to Commercialize Rigosertib for Treatment of Myelodysplastic Syndromes in Latin America
05/03/2018
• Pint Pharma to Make Upfront Investment in Onconova • Onconova also Eligible to Receive up to $42.75 Million in Regulatory and Sales Milestones NEWTOWN, Pa., March 05, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, [...]
Krystal Biotech, Inc. to Present at the 30th Annual ROTH Conference
05/03/2018
PITTSBURGH, March 05, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (NASDAQ: KRYS ), a gene therapy company advancing “off-the-shelf,” treatments for dermatological diseases, today announced that Krish Krishnan, Chief [...]
pSivida To Present at the 30th Annual ROTH Conference
05/03/2018
WATERTOWN, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug products and technologies, announced today that Nancy Lurker, President [...]
Todos Medical initiates clinical trial of its blood test for breast cancer in Kaplan Hospital, Rehovot, Israel for subjects undergoing breast cancer screening
05/03/2018
REHOVOT, Israel, March 05, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTC Pink:TOMDF) ( http://www.Todosmedical.com ) today announced the initiation of its first blinded clinical trial for TM-B1 – a simple blood test [...]
Avinger Announces Participation in Cowen and Company 38th Annual Health Care Conference
05/03/2018
REDWOOD CITY, Calif, March 05, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the Company will be [...]

Pages